AKEBIA THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $635.9M | $104.6M |
| FY2019 | $75.8M | $392.9M | $147.4M |
| FY2020 | $96.4M | $244.4M | $228.7M |
| FY2021 | $0 | $74.0M | $149.8M |
| FY2022 | $34.1M | $5.2M | $90.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $635.9M | $104.6M |
| FY2019 | $75.8M | $392.9M | $147.4M |
| FY2020 | $96.4M | $244.4M | $228.7M |
| FY2021 | $0 | $74.0M | $149.8M |
| FY2022 | $34.1M | $5.2M | $90.5M |